4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-070691
SVP & Chief Commercial Officer acquired 37,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NORTHCOTT JOHN SVP & Chief Commercial Officer | 2021-12-16 | Grant or award | +37,800 | 232,654 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NORTHCOTT JOHN SVP & Chief Commercial Officer | 2021-12-16 | Grant or award · Stock Option | +67,150 | 67,150 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…